AI
MAIA icon

Atria Investments’s MAIA Biotechnology MAIA Stock Holding History

Atria Investments’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.4K Buy
+21,100
New +$28K ﹤0.01% 2109

Other funds holding MAIA

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Atria Investments's MAIA Position: Q2 2026 in Review

Atria Investments opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 21,100 shares worth $30.4K. The stake represents ﹤0.01% of the portfolio and ranks #2109 among its holdings.

5 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Atria Investments held 21,100 shares of MAIA Biotechnology worth $30.4K as of Q2 2026.
  • MAIA Biotechnology was a new Atria Investments position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2109 holding.
  • 5 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.